Summer Master

A new animal model has provided insight into the cellular and molecular mechanisms associated with behavioral therapy for depression. The study, published by Cell Press in the October 9th issue of Neuron, may provide a good model system for testing cellular and molecular interactions between antidepressive medications and behavioral treatments for depression.
generic Read the rest of this entry »

An early
proof-of-concept study presented shows promising results for imatinib
mesylate in the treatment of pulmonary arterial hypertension (PAH), a
severe, incurable blood vessel disorder.
Preliminary findings from a 59-patient, multi-center Phase II clinical
trial suggest imatinib mesylate provides a treatment benefit, as
demonstrated by a significant improvement in pulmonary vascular Read the rest of this entry »

Ute Lawrence is a survivor of one of the most horrific car pile-ups in Canadian history, involving 87 vehicles and killing eight people. The trauma changed her life, bringing personal distress and the end of her 22-years as a Read the rest of this entry »

New York City blacks have the highest rate of high blood pressure of any racial or ethnic group in the city, according to a report released on Wednesday by the New York City Department of Health and Mental Hygiene, the Staten Island Advance reports.
The report — led by Sonia Angell, director of cardiovascular prevention and control at the health department — says that 33% of blacks have the condition, compared Read the rest of this entry »

Millions of patients with treatment-resistant clinical depression, who have struggled for years with disability and how to cope with their condition, now have an option that could help them lead more productive and successful lives.
The NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy system, developed by Neuronetics, Inc. and initiated by research at the Medical University of South Carolina (MUSC), is the first and only approved Read the rest of this entry »